Clinical Trials Logo

Clinical Trial Summary

The blinded RCTstudy aims to:

- Determine the effects of HBOT on burns conversion for patients who have fresh thermal burns injury using the LDI.

- Objectively determine the proportion of burns conversion in areas of partial thickness burns for early thermal burns injury in both arms of the RCT.

- Study the effects of HBOT on immunological markers IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α and TGF-β ( comparison between both arms and 2 assessment points).

- Study the effect of HBOT on haematological markers including procalcitonin ,albumin, lymphocyte counts, neutrophil count, and macrophage count.

- Study the effects of HBOT on histology specimens in quantifying P53 protein, leukocyte and macrophage infiltration, burns depth assessment and vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) .

- Study the effects of HBOT on bacteriology of tissue culture in areas of deep dermal burns.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00824551
Study type Interventional
Source Singapore General Hospital
Contact chong si jack
Phone 65-91467592
Email chong_si_jack@hotmail.com
Status Recruiting
Phase Phase 1
Start date January 2009